<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04108741</url>
  </required_header>
  <id_info>
    <org_study_id>V1 19.09.2019</org_study_id>
    <nct_id>NCT04108741</nct_id>
  </id_info>
  <brief_title>Augmented Reality Treadmill Training in Patients With Parkinson's Disease</brief_title>
  <acronym>Falls in PD</acronym>
  <official_title>Augmented Reality Treadmill Training in Patients With Parkinson's Disease: a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik Valens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinik Valens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients
      during the course. Two methods of gait training will be compared to assess additional
      augmented reality (AR). Treadmill AR training and treadmill training applied over 3 weeks at
      each day will be compared for their impact on falls, walking, freezing and attention for 3
      months in a double blinded randomized controlled Trial during regular neurorehabilitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of falls</measure>
    <time_frame>3 months before study to 3 months following the study</time_frame>
    <description>group difference of the difference in falls</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcomes:</measure>
    <time_frame>before and after the training period of 3 weeks</time_frame>
    <description>Freezing of Gait (FOG) Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Fall</condition>
  <arm_group>
    <arm_group_label>treadmill augmented reality training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>treadmill training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C-Mill augmented reality treadmill training</intervention_name>
    <description>PD Patients will be randomized to treadmill AR training (C-Mill) or treadmill training (C-Mill) for 3 weeks at 5 days a week for 30 minutes.</description>
    <arm_group_label>treadmill augmented reality training</arm_group_label>
    <arm_group_label>treadmill training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed Consent as documented by signature

          -  ParkinsonÂ´s disease without dementia and hallucination

          -  at least one fall within the past 3 months or postural instability

          -  Gait disorder

          -  Hoehn and Yahr stages II-IV

          -  able to perform the treadmill therapy during a study

        Exclusion Criteria:

          -  Contraindications to treadmill therapy (e.g. hip fracture)

          -  Dementia as defined by an Montreal cognitive assessment (MOCA) &lt; 20
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veit Mylius, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, Kliniken Valens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veit Mylius, Prof. Dr.</last_name>
    <phone>0041813031406</phone>
    <email>veit.mylius@kliniken-valens.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology</name>
      <address>
        <city>Valens</city>
        <state>Saint Gallen</state>
        <zip>7317</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veit Mylius, Prof. Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 20, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinik Valens</investigator_affiliation>
    <investigator_full_name>Veit Mylius</investigator_full_name>
    <investigator_title>Priniciple Investigator</investigator_title>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

